Comparative analysis of nanosystems’ effects on human endothelial and monocytic cell functions

References

• Almer, G., D. Frascione, I. Pali-Scholl, C. Vonach, A. Lukschal, C. Stremnitzer, S. C. Diesner, E. Jensen-Jarolim, R. Prassl, and H. Mangge. 2013. “Interleukin-10: An Anti-Inflammatory Marker to Target Atherosclerotic Lesions via PEGylated Liposomes.” Molecular Pharmaceutics 10 (1): 175–186. doi:10.1021/mp300316n.
   PubMed Web of Science ®Google Scholar
• Almer, G., K. Wernig, M. Saba-Lepek, S. Haj-Yahya, J. Rattenberger, J. Wagner, K. Gradauer, D. Frascione, G. Pabst, G. Leitinger, et al., and R. Prassl et al. 2011. “Adiponectin-Coated Nanoparticles for Enhanced Imaging of Atherosclerotic Plaques.” International Journal of Nanomedicine 6: 1279–1290. doi:10.2147/IJN.S18739.
   PubMed Web of Science ®Google Scholar
• Bachelet, L., I. Bertholon, D. Lavigne, R. Vassy, M. Jandrot-Perrus, F. Chaubet, and D. Letourneur. 2009. “Affinity of Low Molecular Weight Fucoidan for P-Selectin Triggers Its Binding to Activated Human Platelets.” Biochimica Et Biophysica Acta 1790 (2): 141–146. doi:10.1016/j.bbagen.2008.10.008.
   PubMed Web of Science ®Google Scholar
• Berry, C. C., and A. S. G. Curtis. 2003. “Functionalisation of Magnetic Nanoparticles for Applications in Biomedicine.” Journal of Physics D: Applied Physics J Phys D Appl Phys 36 (13): R198–R206.
   Web of Science ®Google Scholar
• Bietenbeck, M., A. Florian, C. Faber, U. Sechtem, and A. Yilmaz. 2016. “Remote Magnetic Targeting of Iron Oxide Nanoparticles for Cardiovascular Diagnosis and Therapeutic Drug Delivery: where Where Are We Now?.” International Journal of Nanomedicine Volume11: 3191–3203. doi:10.2147/IJN.S110542.
   Google Scholar
• Chauvierre, C.,. D. Labarre, P. Couvreur, and C. Vauthier. 2003. “Novel Polysaccharide-Decorated Poly(iIsobutyl Cyanoacrylate) Nanoparticles.” Pharmaceutical Research 20 (11): 1786–1793. doi:10.1023/B:PHAM.0000003376.57954.2a.
   PubMed Web of Science ®Google Scholar
• Chauvierre, C.,. D. Labarre, P. Couvreur, and C. Vauthier. 2003. “Radical Emulsion Polymerization of Alkylcyanoacrylates Initiated by the Redox System Dextran-Cerium(IV) under Acidic Aqueous Conditions.” Macromolecules 36 (16): 6018–6027. doi:10.1021/ma034097w.
   Web of Science ®Google Scholar
• Cicha, I., C. D. Garlichs, and C. Alexiou. 2014. “Cardiovascular Therapy through Nanotechnology – How Far Are We Still from Bedside?” European Journal of Nanomedicine 6: 63–87. doi:10.1515/ejnm-2014-0001.
   Google Scholar
• Cicha, I., K. Beronov, E. L. Ramirez, K. Osterode, M. Goppelt-Struebe, D. Raaz, A. Yilmaz, W. G. Daniel, and C. D. Garlichs. 2009. “Shear Stress Preconditioning Modulates Endothelial Susceptibility to Circulating TNF-Alpha and Monocytic Cell Recruitment in a Simplified Model of Arterial Bifurcations.” Atherosclerosis 207 (1): 93–102. doi:10.1016/j.atherosclerosis.2009.04.034.
   PubMed Web of Science ®Google Scholar
• Courant, T., E. Bayon, H. L. Reynaud-Dougier, C. Villiers, M. Menneteau, P. N. Marche, and F. P. Navarro. 2017. “Tailoring Nanostructured Lipid Carriers for the Delivery of Protein Antigens: Physicochemical Properties versus Immunogenicity Studies.” Biomaterials 136: 29–42. doi:10.1016/j.biomaterials.2017.05.001.
   PubMed Web of Science ®Google Scholar
• Cumashi, A., N. A. Ushakova, M. E. Preobrazhenskaya, A. D’Incecco, A. Piccoli, L. Totani, N. Tinari, G. E. Morozevich, A. E. Berman, M. I. Bilan, et al., and N. E. Nifantiev. and I. Consorzio Interuniversitario Nazionale per la Bio-Oncologia et al. 2007. “A Comparative Study of the Anti-Inflammatory, Anticoagulant, Antiangiogenic, and Antiadhesive Activities of Nine Different Fucoidans from Brown Seaweeds.” Glycobiology 17 (5): 541–552. doi:10.1093/glycob/cwm014.
   PubMed Web of Science ®Google Scholar
• Desai, N. 2012. “Challenges in Development of Nanoparticle-Based Therapeutics.” The APS Journal 14 (2): 282–295. doi:10.1208/s12248-012-9339-4.
   Google Scholar
• Desfaits, A. C., O. Serri, and G. Renier. 1999. “Gliclazide Reduces the Induction of Human Monocyte Adhesion to Endothelial Cells by Glycated Albumin.” Diabetes, Obesity and Metabolism 1 (2): 113–120. doi:10.1046/j.1463-1326.1999.00012.x.
   PubMed Web of Science ®Google Scholar
• Gelati, M., E. Corsini, A. Dufour, E. Ciusani, G. Massa, S. Frigerio, C. Milanese, A. Nespolo, and A. Salmaggi. 2009. “Reduced Adhesion of PBMNCs to Endothelium in Methylprednisolone-Treated MS Patients: preliminary Preliminary Results.” Acta Neurologica Scandinavica 96 (5): 283–292. doi:10.1111/j.1600-0404.1997.tb00285.x.
   Google Scholar
• Goppert, T. M., and R. H. Muller. 2005. “Adsorption Kinetics of Plasma Proteins on Solid Lipid Nanoparticles for Drug Targeting.” International Journal of Pharmacy 302 (1-2): 172–186. doi:10.1016/j.ijpharm.2005.06.025.
   PubMedGoogle Scholar
• Goppert, T. M., and R. H. Muller. 2005. “Protein Adsorption Patterns on Poloxamer- and Poloxamine-Stabilized Solid Lipid Nanoparticles (SLN).” European Journal of Pharmaceutics and Biopharmaceutics 60 (3): 361–372. doi:10.1016/j.ejpb.2005.02.006.
   PubMed Web of Science ®Google Scholar
• Gravier, J., F. P. Navarro, T. Delmas, F. Mittler, A. C. Couffin, F. Vinet, and I. Texier. 2011. “Lipidots: competitive Competitive Organic Alternative to Quantum Dots for in In Vivo Fluorescence Imaging.” Journal of Biomedical Optics 16 (9): 096013. doi:10.1117/1.3625405.
   PubMed Web of Science ®Google Scholar
• Hamzah, J., V. R. Kotamraju, J. W. Seo, L. Agemy, V. Fogal, L. M. Mahakian, D. Peters, L. Roth, M. K. Gagnon, K. W. Ferrara, and E. Ruoslahti et al. 2011. “Specific Penetration and Accumulation of a Homing Peptide within Atherosclerotic Plaques of Apolipoprotein E-Deficient Mice.” Proceedings of the National Academy of Sciences of the United States of America 108 (17): 7154–7159. doi:10.1073/pnas.1104540108.
   PubMed Web of Science ®Google Scholar
• Heinzelmann, M., H. C. Polk, Jr., and F. N. Miller. 1998. “Modulation of Lipopolysaccharide-Induced Monocyte Activation by Heparin-bBinding Protein and Fucoidan.” Infection and Immunity 66: 5842–5847.
   PubMed Web of Science ®Google Scholar
• Howarth, S. P. S., T. Y. Tang, R. Trivedi, R. Weerakkody, J. U-King-Im, M. E. Gaunt, J. R. Boyle, Z. Y. Li, S. R. Miller, M. J. Graves, and J. H. Gillard. 2009. Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. European journal of radiology 70:555–560. doi:10.1016/j.ejrad.2008.01.047.
   Google Scholar
• Huwyler, J., J. Drewe, and S. Krahenbuhl. 2008. “Tumor Targeting Using Liposomal Antineoplastic Drugs.” International Journal of Nanomedicine 3: 21–29.
   PubMed Web of Science ®Google Scholar
• Janko, C., S. Durr, L. E. Munoz, S. Lyer, R. Chaurio, R. Tietze, S. Lohneysen, C. Schorn, M. Herrmann, and C. Alexiou et al. 2013. “Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes.” International Journal of Molecular Sciences 14 (4): 7341–7355. doi:10.3390/ijms14047341.
   PubMed Web of Science ®Google Scholar
• Karimi, M., H. Zare, A. Bakhshian Nik, N. Yazdani, M. Hamrang, E. Mohamed, P. Sahandi Zangabad, S. M. Moosavi Basri, L. Bakhtiari, and M. R. Hamblin et al. 2016. “Nanotechnology in Diagnosis and Treatment of Coronary Artery Disease.” Nanomedicine (Lond) 11 (5): 513–530. doi:10.2217/nnm.16.3.
   PubMed Web of Science ®Google Scholar
• Katsuki, S., T. Matoba, S. Nakashiro, K. Sato, J. Koga, K. Nakano, Y. Nakano, S. Egusa, K. Sunagawa, and K. Egashira. 2014. “Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/rRupture in Mice by Regulating the Recruitment of Inflammatory Monocytes.” Circulation 129 (8): 896–906. doi:10.1161/CIRCULATIONAHA.113.002870.
   PubMed Web of Science ®Google Scholar
• Kumar, A., and A. Dhawan. 2013. “Genotoxic and Carcinogenic Potential of Engineered Nanoparticles: An Update.” Archives of Toxicology 87 (11): 1883–1900. doi:10.1007/s00204-013-1128-z.
   PubMed Web of Science ®Google Scholar
• Libby, P., M. DiCarli, and R. Weissleder. 2010. “The Vascular Biology of Atherosclerosis and Imaging Targets.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine J Nucl Med 51( Suppl. 1): 33S–37S. doi:10.2967/jnumed.109.069633.
   PubMedGoogle Scholar
• Lozano, R., M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S. Y. Ahn, et al., and Z. A. Memish. 2012. “Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010.” Lancet 380 (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0.
   PubMed Web of Science ®Google Scholar
• Lyer, S., R. Tietze, R. Jurgons, T. Struffert, T. Engelhorn, E. Schreiber, A. Dorfler, and C. Alexiou. 2010. “Visualisation of Tumour Regression after Local Chemotherapy with Magnetic Nanoparticles - A Pilot Study.” Anticancer Research 30: 1553–1557.
   PubMed Web of Science ®Google Scholar
• Mangge, H., G. Almer, I. Stelzer, E. Reininghaus, and R. Prassl. 2014. “Laboratory Medicine for Molecular Imaging of Atherosclerosis.” Clinica Chimica Acta; International Journal of Clinical Chemistry 437: 19–24. doi:10.1016/j.cca.2014.06.029.
   PubMed Web of Science ®Google Scholar
• Matuszak, J., J. Baumgartner, J. Zaloga, M. Juenet, A. E. da Silva, D. Franke, G. Almer, I. Texier, D. Faivre, J. M. Metselaar, et al., and I. Cicha et al. 2016. “Nanoparticles for Intravascular Applications: physicochemical Physicochemical Characterization and Cytotoxicity Testing.” Nanomedicine (Lond) 11 (6): 597–616. doi:10.2217/nnm.15.216.
   PubMed Web of Science ®Google Scholar
• Merian, J., R. Boisgard, X. Decleves, B. Theze, I. Texier, and B. Tavitian. 2013. “Synthetic Lipid Nanoparticles Targeting Steroid Organs.” Journal of Nuclear Medicine 54 (11): 1996–2003. doi:10.2967/jnumed.113.121657.
   PubMed Web of Science ®Google Scholar
• Müller, R. H., C. Lherm, J. Herbert, and P. Couvreur. 1990. “Invitro Model for the Degradation of Alkylcyanoacrylate Nanoparticles.” Biomaterials 11 (8): 590–595. doi:10.1016/0142-9612(90)90084-4.
   PubMed Web of Science ®Google Scholar
• Muller, R. H.., R. Shegokar, and C. M. Keck. 2011. “20 Years of Lipid Nanoparticles (SLN And NLC): Present State of Development and Industrial Applications.” Current Drug Discovery Technologies 8 (3): 207–227. doi:10.2174/157016311796799062.
   PubMedGoogle Scholar
• Mura, S., and P. Couvreur. 2012. “Nanotheranostics for Personalized Medicine.” Advanced Drug Delivery Reviews 64 (13): 1394–1416. doi:10.1016/j.addr.2012.06.006.
   PubMed Web of Science ®Google Scholar
• Polley, M. J., M. L. Phillips, E. Wayner, E. Nudelman, A. K. Singhal, S. I. Hakomori, and J. C. Paulson. 1991. “Cd62 and Endothelial-Cell Leukocyte Adhesion Molecule-1 (Elam-1) Recognize the Same Carbohydrate Ligand, Sialyl-Lewis-X.” Proceedings of the National Academy of Sciences USA 88 (14): 6224–6228. doi:10.1073/pnas.88.14.6224.
   PubMed Web of Science ®Google Scholar
• Porter, T. R. 2007. “Cardiovascular Imaging of Remote Myocardial Ischemia: detecting Detecting a Molecular Trace of Evidence Left behind.” Circulation 115 (3): 292–293. doi:10.1161/CIRCULATIONAHA.106.675413.
   PubMed Web of Science ®Google Scholar
• Pozo, M., R. de Nicolas, J. Egido, and J. Gonzalez-Cabrero. 2006. “Simvastatin Inhibits the Migration and Adhesion of Monocytic Cells and Disorganizes the Cytoskeleton of Activated Endothelial Cells.” European Journal of Pharmacology 548 (1–3):53–63. doi:10.1016/j.ejphar.2006.08.003.
   PubMed Web of Science ®Google Scholar
• Puri, A., K. Loomis, B. Smith, J. H. Lee, A. Yavlovich, E. Heldman, and R. Blumenthal. 2009. “Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic.” Critical Reviews™ in Therapeutic Drug Carrier Systems reviews in therapeutic drug carrier systems 26 (6): 523–580. doi:10.1615/CritRevTherDrugCarrierSyst.v26.i6.10.
   PubMed Web of Science ®Google Scholar
• Richards, J. M., C. A. Shaw, N. N. Lang, M. C. Williams, S. I. Semple, T. J. MacGillivray, C. Gray, J. H. Crawford, S. R. Alam, A. P. Atkinson, and D. E. Newby. et al. 2012. “In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: feasibility Feasibility and Safety in Humans.” Circulation Cardiovascular Imaging 5 (4): 509–517. doi:10.1161/CIRCIMAGING.112.972596.
   PubMed Web of Science ®Google Scholar
• Rouzet, F., L. Bachelet-Violette, J. M. Alsac, M. Suzuki, A. Meulemans, L. Louedec, A. Petiet, M. Jandrot-Perrus, F. Chaubet, J. B. Michel, and D. Letourneur. et al. 2011. “Radiolabeled Fucoidan as a p-Selectin Targeting Agent for in In Vivo Imaging of Platelet-Rich Thrombus and Endothelial Activation.” Journal of Nuclear Medicine: official Official Publication, Society of Nuclear Medicine 52 (9): 1433–1440. doi:10.2967/jnumed.110.085852.
   PubMed Web of Science ®Google Scholar
• Sadat, U., S. P. Howarth, A. Usman, T. Y. Tang, M. J. Graves, and J. H. Gillard. 2013. “Sequential Imaging of Asymptomatic Carotid Atheroma Using Ultrasmall Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging: A Feasibility Study.” Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association 22 (8): e271–e276. doi:10.1016/j.jstrokecerebrovasdis.2012.06.015.
   PubMed Web of Science ®Google Scholar
• Simoncini, T., S. Maffei, G. Basta, G. Barsacchi, A. R. Genazzani, J. K. Liao, and R. De Caterina. 2000. “Estrogens and Glucocorticoids Inhibit Endothelial Vascular Cell Adhesion Molecule-1 Expression by Different Transcriptional Mechanisms.” Circulation Research 87 (1): 19–25. doi:10.1161/res.87.1.19.
   PubMed Web of Science ®Google Scholar
• Soenen, S. J. H., N. Nuytten, S. F. De Meyer, S. C. De Smedt, and M. De Cuyper. 2010. “High Intracellular Iron Oxide Nanoparticle Concentrations Affect Cellular Cytoskeleton and Focal Adhesion Kinase-Mediated Signaling.” Small 6 (7): 832–842. doi:10.1002/smll.200902084.
   PubMed Web of Science ®Google Scholar
• Sun, G., and J. J. Mao. 2012. “Engineering Dextran-bBased Scaffolds for Drug Delivery and Tissue Repair.” Nanomedicine (London, England) 7 (11): 1771–1784. doi:10.2217/nnm.12.149.
   PubMed Web of Science ®Google Scholar
• Tang, T. Y., K. H. Muller, M. J. Graves, Z. Y. Li, S. R. Walsh, V. Young, U. Sadat, S. P. Howarth, and J. H. Gillard. 2009. “Iron Oxide Particles for Atheroma Imaging.” Arteriosclerosis, Thrombosis, and Vascular Biology 29 (7): 1001–1008. doi:10.1161/ATVBAHA.108.165514.
   PubMed Web of Science ®Google Scholar
• Tietze, R., S. Lyer, S. Durr, T. Struffert, T. Engelhorn, M. Schwarz, E. Eckert, T. Goen, S. Vasylyev, W. Peukert, et al., and C. Alexiou et al.. 2013. “Efficient Drug-Delivery Using Magnetic Nanoparticles–Biodistribution and Therapeutic Effects in Tumour Bearing Rabbits.” Nanomedicine 9 (7): 961–971. doi:10.1016/j.nano.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Trivedi, R. A., C. Mallawarachi, U. K.-I. J. M. M. J. Graves, J. Horsley, M. J. Goddard, A. Brown, L. Wang, P. J. Kirkpatrick, J. Brown, and J. H. Gillard. 2006. “Identifying Inflamed Carotid Plaques Using in In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages.” Arteriosclerosis, Thrombosis, and Vascular Biology 26 (7): 1601–1606. doi:10.1161/01.ATV.0000222920.59760.df.
   PubMed Web of Science ®Google Scholar
• Unterweger, H., L. Dézsi, J. Matuszak, C. Janko, M. Poettler, J. Jordan, T. Bäuerle, J. Szebeni, T. Fey, A R. Boccaccini, C. Alexiou, I. Cicha. 2018. “Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety.” Int J Nanomedicine 8: 1899–1915. doi:10.2147/IJN.S156528. eCollection 2018.
   Google Scholar
• Unterweger, H., C. Janko, M. Schwarz, L. Dézsi, R. Urbanics, J. Matuszak, E. Őrfi, T. Fülöp, T. Bäuerle, J. Szebeni, and I. Cicha. et al. 2017. “Non-iImmunogenic Dextran-Coated Superparamagnetic Iron Oxide Nanoparticles: A Biocompatible, Size-Tunable Contrast Agent for Magnetic Resonance Imaging.” International Journal of Nanomedicine Volume 12: 5223–5238. doi:10.2147/IJN.S138108.
   Web of Science ®Google Scholar
• Unterweger, H., R. Tietze, C. Janko, J. Zaloga, S. Lyer, S. Durr, N. Taccardi, O. M. Goudouri, A. Hoppe, D. Eberbeck, et al., and C. Alexiou et al. 2014. “Development and Characterization of Magnetic Iron Oxide Nanoparticles with a Cisplatin-Bearing Polymer Coating for Targeted Drug Delivery.” International Journal of Nanomedicine 9: 3659–3676. doi:10.2147/IJN.S63433.
   PubMed Web of Science ®Google Scholar
• van der Geest, T., J. M. Metselaar, D. Gerrits, P. L. van Lent, G. Storm, P. Laverman, and O. C. Boerman. 2015. “[(18)]F FDG PET/CT Imaging to Monitor the Therapeutic Effect of Liposome-Encapsulated Prednisolone in Experimental Rheumatoid Arthritis.” Journal of Controlled Release 209:20–26. doi:10.1016/j.jconrel.2015.04.019.
   PubMed Web of Science ®Google Scholar
• Wermuth, P. J., and S. A. Jimenez. 2014. “Induction of a Type I Interferon Signature in Normal Human Monocytes by Gadolinium-Based Contrast Agents: comparison Comparison of Linear and Macrocyclic Agents. Clinical and.” Clinical & Experimental Immunology experimental immunology 175 (1): 113–125. doi:10.1111/cei.12211.
   PubMed Web of Science ®Google Scholar
• Wong, B., W. C. Lumma, A. M. Smith, J. T. Sisko, S. D. Wright, and T. Q. Cai. 2001. “Statins Suppress THP-1 Cell Migration and Secretion of Matrix Metalloproteinase 9 by Inhibiting Geranylgeranylation.” Journal of Leukocyte Biology 69: 959–962. doi:10.1189/jlb.69.6.959.
   PubMed Web of Science ®Google Scholar
• Zaloga, J., C. Janko, J. Nowak, J. Matuszak, S. Knaup, D. Eberbeck, R. Tietze, H. Unterweger, R. P. Friedrich, S. Duerr, et al., and C. Alexiou. 2014. “Development of a Lauric Acid/Albumin Hybrid Iron Oxide Nanoparticle System with Improved Biocompatibility.” International Journal of Nanomedicine 9: 4847–4866. doi:10.2147/IJN.S68539.
   PubMed Web of Science ®Google Scholar
• Zandberg, W. F., J. Kumarasamy, B. M. Pinto, and D. J. Vocadlo. 2012. “Metabolic Inhibition of Sialyl-Lewis X Biosynthesis by 5-Thiofucose Remodels the Cell Surface and Impairs Selectin-Mediated Cell Adhesion.” Journal of Biological Chemistry The Journal of biological chemistry 287 (47): 40021–40030. doi:10.1074/jbc.M112.403568.
   PubMed Web of Science ®Google Scholar
• Zhang, W. J., and B. Frei. 2002. “Albumin Selectively Inhibits TNF Alpha-Induced Expression of Vascular Cell Adhesion Molecule-1 in Human Aortic Endothelial Cells.” Cardiovascular Research 55 (4): 820–829. doi:10.1016/S0008-6363(02)00492-3.
   PubMed Web of Science ®Google Scholar
• Zolnik, B. S., A. Gonzalez-Fernandez, N. Sadrieh, and M. A. Dobrovolskaia. 2010. “Nanoparticles and the Immune System.” Endocrinology 151 (2): 458–465. doi:10.1210/en.2009-1082.
   PubMed Web of Science ®Google Scholar